Searchable abstracts of presentations at key conferences in endocrinology

ea0041d1.2 | The use of NSAIDs in endocrine cancers: the case of Celecoxib | ECE2016

The use of NSAIDs in endocrine cancers: the case of Celecoxib: FOR

Carles Joan

NSAIDs inhibit cyclooxygenase activity and thereby reduce prostaglandin synthesis. Two genetic isoforms of COX have been characterized: COX 1 constituvely produced in most tissues and COX 2 is not expressed in most normal tissues which is induced by pro inflammatory and mitogenic stimuli. Chronic inflammation and oxidative stress are key players in COX2 dependent carcinogenesis and it is important to point out that this type of inflammation has been associated with cancer in d...

ea0073aep476 | Pituitary and Neuroendocrinology | ECE2021

Growth Hormone (GH) treatment in adults with Prader-Willi Syndrome (PWS) restores plasma kisspeptin to normal levels

Olga Giménez-Palop , Casamitjana Laia , Corripio Raquel , Rocío Pareja , Oliva Joan Carles , Néstor Albiñana , Neus Gómez Gerique , Rigla Mercedes , Assumpta Caixàs

BackgroundCentral kisspeptin action is well known in reproductive regulation; however, its peripheral action is not well understood. Most studies reveal that kisspeptin signaling influences energy and metabolic status.ObjectiveTo compare serum kisspeptin levels 1) between adult patients with PWS, obese subjects matched for age, sex and BMI and healthy subjects; 2) in adult patients with PWS before and after t...